The journal "Minerva Medica" has published a study of the safety of IV therapy in 200 patients with neurological Lyme disease. The study concludes that with proper care of the IV device, risk to the patient is low. Read More »
LymeDisease.org is a non-profit
501(c)(3) that serves the patient community through advocacy, education and research.
Federal EIN-68-0214101
Support LymeDisease.org
Become a member.
Comments? Questions?
Ask your questions here.